LONDON (Alliance News) - AstraZeneca PLC on Thursday posted strongly positive results from a phase two study of Fasenra in patients with hypereosinophilic syndrome, including a near-complete of in Read More
LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - WINNERS----------Hargreaves Read More
LONDON (Alliance News) - Stock prices in London opened higher on Tuesday following a strong close in the US overnight, with the FTSE 100 supported by weakness in the pound, which slipped amid yet Read More
LONDON (Alliance News) - AstraZeneca PLC on Monday said its drug selumetinib has been granted a breakthrough therapy designation in the US for neurofibromatosis type 1.Neurofibromatosis 1 1 Read More
LONDON (Alliance News) - AstraZeneca PLC said Friday afternoon it has completed a placing of 44.4 million shares at GBP60.50 each raising GBP2.69 billion, or USD3.5 billion.The placing a to Read More
LONDON (Alliance News) - Stocks in London ended higher on Friday amid continued optimism over the ongoing trade talks between the US and China.In a post on Twitter this morning, Treasury Secretary Read More
LONDON (Alliance News) - London share prices were higher at midday Friday, with the FTSE 100 lifted by mining stocks amid optimism over US-China trade talks and despite significant hits to and 100 Read More
LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.----------FTSE 100 - up 2.5%, Glencore, up 2.6%, Read More
LONDON (Alliance News) - Stocks in London opened in the green on Friday, ahead another key day for the UK's future with the EU, with the FTSE 100 higher despite declines by and Read More
LONDON (Alliance News) - Stock prices in London are called for a positive start on Friday, following Asian markets higher after progress was reported in talks between the US and China. IG futures Read More
LONDON (Alliance News) - Stock prices in London are seen opening in the green on Friday, with investors welcoming reports of progress between the US and China on trade.Meanwhile, has signed Read More
LONDON (Alliance News) - AstraZeneca PLC's lung cancer drug Imfinzi will be paid for by the UK National Health Service for use by eligible patients following approval by a UK regulator, it was Read More
LONDON (Alliance News) - FTSE 100-listed drug maker AstraZeneca PLC said Wednesday its blockbuster Forxiga drug had been approved by Japan for the treatment of diabetes alongside Japanese Ministry Read More
LONDON (Alliance News) - Stocks in London are set to open in positive territory on Wednesday, extending the previous session's gains as worries over the health of the global economy eased. In Read More
LONDON (Alliance News) - Stock prices in London are seen opening in the red on Monday, tracking Asian equity markets lower following heavy losses in the US on Friday, amid fears of an impending US Read More
LONDON (Alliance News) - AstraZeneca PLC on Monday said the first sub-analyses from its phase three trial of Farxiga found it reduced the relative risk of major adverse cardiovascular events in a Read More
LONDON (Alliance News) - Stock prices in London are seen opening in the green on Monday following strong gains in Asian equity markets overnight, amid hopes that a trade resolution between the US Read More
LONDON (Alliance News) - TI Fluid Systems PLC said Friday it hired former AstraZeneca PLC and Wincanton PLC executive Andrea Dunstan as a non-executive director at the liquid handling systems with Read More
LONDON (Alliance News) - AstraZeneca PLC on Friday said a committee of the European Medicines Agency has recommended cancer drug Lynparza for use in incurable breast cancer patients.The for Read More
LONDON (Alliance News) - FTSE 100-listed drugmaker AstraZeneca PLC and its partner Merck & Co Inc said Tuesday its potentially blockbuster Lynparza cancer treatment had met the primary of one Read More